Overview
Young syndrome, also known as Barry-Perkins-Young syndrome or obstructive azoospermia with chronic sinopulmonary infections, is a rare condition characterized by a clinical triad of chronic sinusitis, bronchiectasis, and obstructive azoospermia (absence of sperm in the ejaculate due to obstruction). The syndrome predominantly affects males and shares clinical features with cystic fibrosis and primary ciliary dyskinesia, though it is considered a distinct entity. The obstructive azoospermia results from inspissation (thickening) of secretions in the epididymis, leading to blockage of sperm transport despite normal spermatogenesis in the testes. The chronic sinopulmonary disease involves recurrent sinus infections and progressive bronchiectasis with chronic productive cough, likely related to abnormal mucus clearance in the respiratory tract. The exact cause of Young syndrome remains unclear. Some cases have been linked to mercury exposure during childhood (e.g., through mercury-containing teething powders historically used in certain countries), though this association is not fully established, and the condition may also occur without such exposure. The genetic basis, if any, has not been definitively identified. Diagnosis is typically made clinically based on the characteristic triad of symptoms, supported by semen analysis showing azoospermia, imaging demonstrating bronchiectasis, and exclusion of cystic fibrosis (normal sweat chloride test and absence of CFTR mutations) and primary ciliary dyskinesia (normal ciliary ultrastructure). Treatment is primarily supportive and symptom-directed. Respiratory management includes chest physiotherapy, airway clearance techniques, and antibiotics for pulmonary infections to slow the progression of bronchiectasis. Sinusitis is managed with nasal irrigation, decongestants, and antibiotics as needed. For infertility, microsurgical epididymal sperm aspiration (MESA) combined with intracytoplasmic sperm injection (ICSI) may be offered to achieve biological fatherhood. There is currently no curative treatment for Young syndrome.
Clinical phenotype terms— hover any for plain English:
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsMassachusetts General Hospital — NA
Columbia University — NA
Chang Gung Memorial Hospital — NA
Wei XIA, PhD
University of Alabama at Birmingham — PHASE4
Centre for Infectious Disease Research in Zambia — NA
Massachusetts General Hospital — NA
University of Edinburgh
University of Edinburgh
Izmir Democracy University — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availablePulmozyme
indicated, in conjunction with standard therapies, for the management of pediatric and adult patients with cystic fibrosis (CF) to improve pulmonary function
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Young syndrome.
Community
No community posts yet. Be the first to share your experience with Young syndrome.
Start the conversation →Latest news about Young syndrome
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Young syndrome
What is Young syndrome?
Young syndrome, also known as Barry-Perkins-Young syndrome or obstructive azoospermia with chronic sinopulmonary infections, is a rare condition characterized by a clinical triad of chronic sinusitis, bronchiectasis, and obstructive azoospermia (absence of sperm in the ejaculate due to obstruction). The syndrome predominantly affects males and shares clinical features with cystic fibrosis and primary ciliary dyskinesia, though it is considered a distinct entity. The obstructive azoospermia results from inspissation (thickening) of secretions in the epididymis, leading to blockage of sperm tran
At what age does Young syndrome typically begin?
Typical onset of Young syndrome is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Young syndrome?
Yes — 1 recruiting clinical trial is currently listed for Young syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Young syndrome?
25 specialists and care centers treating Young syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Young syndrome?
1 patient support program are currently tracked on UniteRare for Young syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.